Health ❯ Healthcare ❯ Pharmaceuticals ❯ Weight Loss Drugs

Novo Nordisk

GSK Gains After Cramer Endorsement as Company Pushes Into Weight-Loss Drugs

The move underscores investor interest in its weight-loss push.

Novo Nordisk to Cut U.S. List Prices for Wegovy, Ozempic and Rybelsus to $675 in 2027

Bitcoin Retreats to $113,000 as Liquidations and Rate-Cut Jitters Hit Crypto